In a study recently published within the journal BMJ opena gaggle of researchers evaluated whether newer Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including semaglutide and tirzepatide, are related to a lower risk of alcohol-related emergency department visits (ED) Visits or hospitalizations for adults with alcohol use disorder (AUD) and kind 2 diabetes (T2D) or obesity. […]
